Skip to Main Content

Paper Details

Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab.
J Immunother Cancer
8
2020
Author NameAffiliation
Wei YuanRoyal Marsden Hospital/ Institute of Cancer Research
Susana MirandaRoyal Marsden Hospital/ Institute of Cancer Research
Nina TunariuRoyal Marsden Hospital/ Institute of Cancer Research
Suzanne CarreiraRoyal Marsden Hospital/ Institute of Cancer Research
Johann S de BonoRoyal Marsden Hospital/ Institute of Cancer Research
  • 1 - 5

Datasets

Release 1.2